Searched for
PHASE II AND III CLINICAL TRIALS
On This Day in History, June 26: UN Charter signed, Indira Gandhi declares Emergency, Harry Potter debuts, Corvette day, Sher Shah Suri wins against Mughals and moreOn This Day in History, June 26 saw the signing of the United Nations Charter, Richard III's rise to the English throne, India's declaratio...- Amazon to invest additional $13 billion in India AI, cloud infrastructure by 2030Amazon is injecting an additional $13 billion into India's AI and cloud infrastructure by 2030, bringing its total planned investment to ov...
- Long- or medium-term: Invest in ability and balance sheet; 5 large-caps from different sectors with upside potential of up to 23%At this juncture, what an investor in the market needs is some hard work and the ability to be contrarian. In picking companies, focus on t...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- 71% of MSMEs on TReDS platform now come from Tier-II and smaller cities: M1xchange reportMSMEs from Tier II, III, and beyond now constitute a significant portion of platform users and transaction volume. This digital financing e...
- Areion Assets Management launches $60 million AIF to tap India's special situations marketAreion Assets Management has launched a $60 million Category III AIF from GIFT City targeting India’s special situations market. The fund w...
- Best medium to long duration funds to invest in June 2026Conservative investors are steered towards safer, short-term debt funds, often overlooking medium to long duration options due to their inh...
- Shaan Patel Asset Management launches Rs 250 crore Quant IPO Opportunity Fund under Category III AIFShaan Patel Asset Management has launched a Rs 250 crore Quant IPO Opportunity Fund under the Category III AIF route to tap opportunities i...
- Bodycraft Clinic and Salon raises Rs 120 crore in fundingBodycraft Clinic and Salon has secured Rs 120 crore funding from Singularity AMC to fuel its expansion across India. The integrated beauty,...
- Centre, Telangana appoint SBI Caps to evaluate Hyderabad Metro takeover, Phase-II expansionHyderabad Metro's future is set for a new direction as the Centre and Telangana government have agreed to appoint SBI Capital Markets. This...
- Google's YouTube settles case over social media harm to childrenThe terms of the settlement of the state court lawsuit were confidential, the lawyers said on Tuesday. The suit named four defendants - You...
- Achraf Hakimi of Morocco is playing against Scotland despite France court declares he must stand trialMorocco coach Mohamed Ouahbi decided to start with Achraf Hakimi despite the controversy.
- Karnataka CM Shivakumar's first wish list: Water share, Bengaluru infra boostKarnataka Chief Minister DK Shivakumar has presented his first wish list to the Centre. His top priorities include securing the state's rig...
- Multibagger HFCL shares hit 5% upper circuit for second session. What’s triggering the surge?HFCL shares surged significantly after securing a substantial contract from Rail Vikas Nigam Limited. This order bolsters HFCL's standing i...
- HealthQuad raises Rs 550 crore, eyes Rs 1,700 crore fundHealthQuad has secured Rs 550 crore for its third fund. The venture capital firm aims to raise Rs 1,700 crore to back early-growth companie...
- Best conservative hybrid mutual funds to invest in June 2026Mutual fund advisors are predicting 2026 as the year for hybrid funds, especially for new investors navigating economic uncertainties. Cons...
- Korean food startup Gimi Michi raises $1 million led by IndiaQuotientFounded by IIM Ahmedabad alumni Nishank Goyal, Akhil Kumar, and Bodhi Rathor, Gimi Michi is building a Korean food brand for the Indian mar...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
Load More
